The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Gilead Sciences to Present at the 23rd Annual Piper Jaffray Healthcare Conference on Tuesday, November 29

<p class='bwalignc'> <i><b>Webcast Available Through Gilead Corporate Website</b></i> </p>

Monday, November 28, 2011

Gilead Sciences to Present at the 23rd Annual Piper Jaffray Healthcare Conference on Tuesday, November 2916:30 EST Monday, November 28, 2011 FOSTER CITY, Calif. (Business Wire) -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 23rd Annual Piper Jaffray Healthcare Conference in New York. John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will provide an overview of the company on Tuesday, November 29 at 9:00 a.m. Eastern Time. To access the live webcast or a replay via the Internet, log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation. About Gilead Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific. For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235). Gilead Sciences, Inc.Susan Hubbard, 650-522-5715 (Investor Relations)www.gilead.com